The company's average rating is Strong Buy from 2 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Inspiremd market sentiment investors' perception of the future value of Inspiremd. Let us look at a few aspects of Inspiremd technical analysis. About
12.0% of the company outstanding shares are owned by corporate insiders. The book value of Inspiremd was now reported as 0.31. Inspiremd recorded a loss per share of
0.65. The entity had not issued any dividends in recent years. The firm had
1:4 split on the 1st of April 2019.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of InspireMD. In general, sophisticated investors focus on analyzing InspireMD stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build InspireMD's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of
InspireMD's intrinsic value. In addition to deriving basic predictive indicators for InspireMD, many experienced traders also check how macroeconomic factors affect InspireMD price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of InspireMD's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InspireMD. Your research has to be compared to or analyzed against InspireMD's peers to derive any actionable benefits. When done correctly, InspireMD's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in InspireMD.
How important is InspireMD's Liquidity
InspireMD
financial leverage refers to using borrowed capital as a funding source to finance InspireMD ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. InspireMD financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to InspireMD's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of InspireMD's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between InspireMD's total debt and its cash.
InspireMD Gross Profit
InspireMD Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing InspireMD previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show InspireMD Gross Profit growth over the last 10 years. Please check InspireMD's
gross profit and other
fundamental indicators for more details.
Closer look at Inspiremd Mean Deviation
Inspiremd has current Mean Deviation of 7.32. The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns.
Mean Deviation is the average of the absolute values of the differences between price distribution numbers and their mean. Mean deviation of equity instrument with a lot of historical data is a biased estimator because the time horizon used in calculation will always be much smaller than the entire price history of the equity. The mean deviation is typically used as a measure of dispersion for small investment horizon, otherwise standard deviation is a better measure of dispersion.
Mean Deviation | = | SUM(RET DEV) N |
| = | 7.32 |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Inspiremd |
| N | = | Number of calculation points for selected time horizon |
Let's now compare Inspiremd Mean Deviation to its closest peers:
| NSPR | 7.32193353168044 |
| EW | 1.23 |
| DYNT | 4.56 |
| ECIA | 3.99 |
| ECTE | 20.71 |
Will Inspiremd fall impact its fundamentals?
Inspiremd latest information ratio advances over 0.14. Inspiremd is displaying above-average volatility over the selected time horizon. Investors should scrutinize Inspiremd independently to ensure intended market timing strategies are aligned with expectations about Inspiremd volatility. Inspiremd is a potential penny stock. Although Inspiremd may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Inspiremd. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Inspiremd instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
Our Bottom Line On Inspiremd
While some other firms in the medical devices industry are either recovering or due for a correction, Inspiremd may not be as strong as the others in terms of longer-term growth potentials. The bottom line, as of the 9th of March 2021, we believe that at this point, Inspiremd is
undervalued with
high probability of distress within the next 2 years. Our overall recommendation on the enterprise is
Strong Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of InspireMD. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com